Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers

Journal of General Internal Medicine

Volumn 23, Issue 9, 2008, Pages 1393-1398

  Walley, Alexander Y ^a,e   Alperen, Julie K ^c   Cheng, Debbie M ^a,d   Botticelli, Michael ^b   Castro Donlan, Carolyn ^b   Samet, Jeffrey H ^a,d   Alford, Daniel P ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

Buprenorphine; Medication assisted treatment; Opioid dependence

Indexed keywords

BUPRENORPHINE; METHADONE; NALOXONE; OPIATE;

ARTICLE; CLINICAL PRACTICE; CONFIDENCE INTERVAL; DRUG DEPENDENCE; DRUG SCREENING; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAINTENANCE THERAPY; MEDICAL RECORD; MEDICAL SPECIALIST; PATIENT COUNSELING; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PSYCHIATRIST; QUESTIONNAIRE; UNITED STATES;

BUPRENORPHINE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; HUMANS; MASSACHUSETTS; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRIVATE PRACTICE; PSYCHIATRY;

EID: 50049100351     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0686-x     Document Type: Article

References (24)

1. Center for Substance Abuse Treatment, Substance Abuse Treatment and Mental Health Services Administration, US Department of Health and Human Services. The determinations report: A report on the physician waiver program established by the Drug Addiction Treatment Act of 2000 ("DATA"). Available at: buprenorphine.samhsa.gov/SAMHSA_Determinations_Report.pdf. Accessed: May 16, 2008.
2. J Kakko KD Svanborg MJ Kreek M Heilig 2003 One-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial Lancet 361 9358 662 668
3. DP Alford CT LaBelle JM Richardson 2007 Treating homeless opioid dependent patients with buprenorphine in an office-based setting J Gen Intern Med 22 2 171 176
4. MD Stein P Cioe PD Friedmann 2005 Buprenorphine retention in primary care J Gen Intern Med 20 11 1038 1041
5. IL Mintzer M Eisenberg M Terra C MacVane DU Himmelstein S Woolhandler 2007 Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings Ann Fam Med 5 2 146 150
6. S Magura SJ Lee EA Salsitz 2007 Outcomes of buprenorphine maintenance in office-based practice J Addict Dis 26 2 13 23
7. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2004;(3):CD002207
8. RE Johnson JH Jaffe PJ Fudala 1992 A controlled trial of buprenorphine treatment for opioid dependence JAMA 267 20 2750 2755
9. RE Johnson MA Chutuape EC Strain SL Walsh ML Stitzer GE Bigelow 2000 A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence N Engl J Med 343 18 1290 1297
10. PJ Fudala TP Bridge S Herbert 2003 Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone N Engl J Med 349 10 949 948
11. PG O'Connor KM Carroll JM Shi RS Schottenfeld TR Kosten BJ Rounsaville 1997 Three Methods of Opioid Detoxification in a Primary Care Setting: A Randomized Trial Ann Intern Med 127 7 526 530
12. W Ling C Charuvastra JF Collins 1998 Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial Addiction 93 4 475 486
13. Drug Addiction Treatment Act of 2000. Public Law 106-310, Page 114 STAT.1101-Page 114 STAT.1227. 8-2-0005.
14. Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40.DHHS Publication No. (SMA) 04-3939. 2004. Rockville, MD.
15. Confidentiality of Alcohol and Drug Abuse Patient Records. Code of Federal Regulations Title 42, Volume 1, Chapter 1, Part 2. Available at: http://www.2hs.gov/ohrp/documents/19750701.pdf. Accessed: May 16, 2008.
16. Bivol, S. National poll of physicians on barriers to widespread buprenorphine use. 2003. Boston, Join Together. 8-29-2007.
17. W Kissin C McLeod J Sonnefeld A Stanton 2006 Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence J Addict Dis 25 4 91 103
18. Center for Health Information, Statistics, Research, and Evaluation, Bureau of Substance Abuse Services, Massachusetts Department of Public Health. Opioids: Trends and Current Status in Massachusetts. Available at: www.mass.gov/Eeohhs2/docs/dph/injury_surveillance/opioid_trends_2007.doc. Accessed: May 16, 2008.
19. JC West TR Kosten J Wilk 2004 Challenges in increasing access to buprenorphine treatment for opiate addiction Am J Addict 13 Suppl 1 S8 S16
20. FD Wolinsky 1982 Why physicians choose different types of practice settings Health Serv Res 17 4 399 419
21. JM Gaulier P Marquet E Lacassie JL Dupuy G Lachatre 2000 Fatal intoxication following self-administration of a massive dose of buprenorphine J Forensic Sci 45 1 226 228
22. WC Becker DA Fiellin 2005 Provider satisfaction with office-based treatment of opioid dependence: a systematic review Subst Abus 26 1 15 22
23. CO Cunningham HV Kunins RJ Roose RT Elam NL Sohler 2007 Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians J Gen Intern Med 22 9 1325 1329
24. BJ Turner C Laine YT Lin K Lynch 2005 Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence Arch Intern Med 165 15 1769 1776